{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:16:55Z","timestamp":1761167815124,"version":"build-2065373602"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.ghir.2020.101362","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:57:09Z","timestamp":1604278629000},"page":"101362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Endothelial dysfunction in patients with acromegaly and It's association with Endocan"],"prefix":"10.1016","volume":"56","author":[{"given":"Seref","family":"Kul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozge Telci","family":"Caklili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"Tutuncu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma Betul","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feyza","family":"Aksu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer Faruk","family":"Baycan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adem","family":"Atici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ummuhan Zeynep","family":"Bilgili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mumtaz","family":"Takir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Caliskan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ghir.2020.101362_bb0005","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2020.101362_bb0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly: epidemiology, pathogenesis, and management","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr. Rev."},{"issue":"3","key":"10.1016\/j.ghir.2020.101362_bb0015","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur. J. Endocrinol."},{"year":"2012","series-title":"Predictors of Morbidity and Mortality in Acromegaly: An Italian Survey","author":"Arosio","key":"10.1016\/j.ghir.2020.101362_bb0020"},{"issue":"7","key":"10.1016\/j.ghir.2020.101362_bb0025","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1210\/jcem.87.7.8573","article-title":"Cardiovascular consequences of early-onset growth hormone excess","volume":"87","author":"Colao","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.ghir.2020.101362_bb0030","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1046\/j.1365-2265.2001.01256.x","article-title":"Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly","volume":"54","author":"Colao","year":"2001","journal-title":"Clin. Endocrinol."},{"issue":"1","key":"10.1016\/j.ghir.2020.101362_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1742-1241.2008.01750.x","article-title":"Investigation of early atherosclerotic changes in acromegalic patients","volume":"64","author":"Kartal","year":"2010","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ghir.2020.101362_bb0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.atherosclerosis.2017.12.019","article-title":"Coronary microvascular dysfunction may be related to IGF-1 in acromegalic patients and can be restored by therapy","volume":"269","author":"Tellatin","year":"2018","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.ghir.2020.101362_bb0045","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/crj.12487","article-title":"Endocan: a novel predictor of endothelial dysfunction in obstructive sleep apnea syndrome","volume":"12","author":"Kanbay","year":"2018","journal-title":"Clin. Respir. J."},{"issue":"12","key":"10.1016\/j.ghir.2020.101362_bb0050","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/jch.12440","article-title":"Endocan: a new molecule playing a role in the development of hypertension and chronic kidney disease?","volume":"16","author":"Afsar","year":"2014","journal-title":"J. Clin. Hypertension"},{"issue":"6","key":"10.1016\/j.ghir.2020.101362_bb0055","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/ki.2014.227","article-title":"Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease","volume":"86","author":"Yilmaz","year":"2014","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.ghir.2020.101362_bb0060","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jcp.24485","article-title":"Endocan elicits severe vascular inflammatory responses in vitro and in vivo","volume":"229","author":"Lee","year":"2014","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.ghir.2020.101362_bb0065","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1540-8175.2006.00342.x","article-title":"Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow-mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter","volume":"23","author":"Gullu","year":"2006","journal-title":"Echocardiography"},{"issue":"2","key":"10.1016\/j.ghir.2020.101362_bb0070","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0735-1097(01)01746-6","article-title":"Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force","volume":"39","author":"Corretti","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ghir.2020.101362_bb0075","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/EJE-16-1064","article-title":"Changes in the management and comorbidities of acromegaly over three decades: the French acromegaly registry","volume":"176","author":"Maione","year":"2017","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"10.1016\/j.ghir.2020.101362_bb0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Li\u00e8ge acromegaly survey (LAS) database","volume":"24","author":"Petrossians","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ghir.2020.101362_bb0085","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1210\/jc.2007-1213","article-title":"Risk factors for development of coronary heart disease in patients with acromegaly: a five-year prospective study","volume":"92","author":"Bogazzi","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101362_bb0090","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1161\/01.RES.0000021127.83364.7D","article-title":"Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression","volume":"90","author":"Che","year":"2002","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.ghir.2020.101362_bb0095","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12020-018-1797-8","article-title":"Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bic\u00eatre cohort, and review of the literature","volume":"63","author":"Briet","year":"2019","journal-title":"Endocrine."},{"issue":"6","key":"10.1016\/j.ghir.2020.101362_bb0100","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1046\/j.1365-2265.1998.00620.x","article-title":"Decreased regional blood flow in patients with acromegaly","volume":"49","author":"Chanson","year":"1998","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.ghir.2020.101362_bb0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000204355","article-title":"Impairment in flow-mediated vasodilatation of the brachial artery in acromegaly","volume":"18","author":"Baykan","year":"2009","journal-title":"Med. Principle. Pract."},{"key":"10.1016\/j.ghir.2020.101362_bb0110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1742-1241.2008.01750.x","article-title":"Investigation of early atherosclerotic changes in acromegalic patients","volume":"64","author":"Kartal","year":"2010","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.ghir.2020.101362_bb0115","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1210\/jcem.87.7.8643","article-title":"Early vascular alterations in acromegaly","volume":"87","author":"Brevetti","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101362_bb0120","doi-asserted-by":"crossref","unstructured":"Sakai H, Tsuchiya K, Nakayama C, Iwashima F, Izumiyama H, Doi M, Yoshimoto T, Tsujino M, Yamada S, Hirata Y. Improvement of endothelial dysfunction in acromegaly after transsphenoidal surgery. Endocrine journal. 2008:0805020131-.","DOI":"10.1507\/endocrj.K07E-125"},{"key":"10.1016\/j.ghir.2020.101362_bb0125","doi-asserted-by":"crossref","DOI":"10.1042\/CS20100400","article-title":"IGF-1 and atherothrombosis: relevance to pathophysiology and therapy","volume":"120","author":"Conti","year":"2011","journal-title":"Clin. Sci."},{"key":"10.1016\/j.ghir.2020.101362_bb0130","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2003-030967","article-title":"The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the rancho Bernardo study","volume":"89","author":"Laughlin","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101362_bb0135","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/EJE-08-0452","article-title":"IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population","volume":"160","author":"Andreassen","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2020.101362_bb0140","doi-asserted-by":"crossref","first-page":"H815","DOI":"10.1152\/ajpheart.1999.276.3.H815","article-title":"Inhibition of NO synthesis or endothelium removal reveals a vasoconstrictor effect of insulin on isolated arterioles","volume":"276","author":"Schroeder","year":"1999","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ghir.2020.101362_bb0145","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1210\/endo.137.5.8612517","article-title":"Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide","volume":"137","author":"Walsh","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2020.101362_bb0150","doi-asserted-by":"crossref","first-page":"E176","DOI":"10.1152\/ajpendo.2000.279.1.E176","article-title":"Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size","volume":"279","author":"Oltman","year":"2000","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101362_bb0155","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s10439-013-0957-5","article-title":"Endothelial insulin-like growth factor-1 modulates proliferation and phenotype of smooth muscle cells induced by low shear stress","volume":"42","author":"Wang","year":"2014","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.ghir.2020.101362_bb0160","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1210\/jc.2010-2225","article-title":"Changes in arterial stiffness but not carotid intimal thickness in acromegaly","volume":"96","author":"Paisley","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2020.101362_bb0165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.HYP.34.1.89","article-title":"Attenuated in vitro coronary arteriolar vasorelaxation to insulin-like growth factor I in experimental hypercholesterolemia","volume":"34","author":"Hasdai","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ghir.2020.101362_bb0170","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1161\/01.ATV.0000105902.89459.09","article-title":"Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels","volume":"24","author":"Delafontaine","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2020.101362_bb0175","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/j.1582-4934.2010.01161.x","article-title":"Cross-talk between angiotensin II and IGF-1-induced connexin 43 expression in human saphenous vein smooth muscle cells","volume":"15","author":"Jia","year":"2011","journal-title":"J. Cell. Mol. Med."},{"issue":"1","key":"10.1016\/j.ghir.2020.101362_bb0180","first-page":"25","article-title":"Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy","volume":"1765","author":"Sarrazin","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.ghir.2020.101362_bb0185","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.atherosclerosis.2011.05.034","article-title":"Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: the PRIME study","volume":"218","author":"Ruidavets","year":"2011","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.ghir.2020.101362_bb0190","first-page":"1021","article-title":"The cardiovascular system in growth hormone excess and growth hormone deficiency","volume":"35","author":"Lombardi","year":"2012","journal-title":"J. Endocrinol. Invest."},{"issue":"Suppl. A","key":"10.1016\/j.ghir.2020.101362_bb0195","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.ghir.2006.03.006","article-title":"Beginning to end: cardiovascular implications of growth hormone (GH) deficiency and GH therapy","volume":"16","author":"Colao","year":"2006","journal-title":"Growth Horm. IGF Res."},{"key":"10.1016\/j.ghir.2020.101362_bb0200","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1210\/jc.2005-0597","volume":"90","author":"Colao","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"10.1016\/j.ghir.2020.101362_bb0205","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1161\/ATVBAHA.107.156257","article-title":"IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice","volume":"27","author":"Sukhanov","year":"2007","journal-title":"Arteriosclerosis Thrombosis Vascular Biol."},{"issue":"15","key":"10.1016\/j.ghir.2020.101362_bb0210","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1158\/1078-0432.CCR-06-0185","article-title":"Endocan expression and relationship with survival in human non-small cell lung cancer","volume":"12","author":"Grigoriu","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"23","key":"10.1016\/j.ghir.2020.101362_bb0215","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.3748\/wjg.v22.i23.5422","article-title":"Endocan-expressing microvessel density as a prognostic factor for survival in human gastric cancer","volume":"22","author":"Chang","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.ghir.2020.101362_bb0220","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10549-016-4057-8","article-title":"Endocan as a prognostic biomarker of triple-negative breast cancer","volume":"161","author":"Sagara","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.ghir.2020.101362_bb0225","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7150\/jca.7691","article-title":"Serum endocan as a novel prognostic biomarker in patients with hepatocellular carcinoma","volume":"5","author":"Ozaki","year":"2014","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.ghir.2020.101362_bb0230","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s11060-014-1377-6","article-title":"Endocan, a new invasion and angiogenesis marker of pituitary adenomas","volume":"117","author":"Matano","year":"2014","journal-title":"J. Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.ghir.2020.101362_bb0235","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s11102-015-0698-6","article-title":"A comparative analysis of ESM1 and vascular endothelial cell marker (CD34\/CD105) expression on pituitary adenoma invasion","volume":"19","author":"Miao","year":"2016","journal-title":"Pituitary"},{"issue":"6","key":"10.1016\/j.ghir.2020.101362_bb0240","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1750-3639.2012.00578.x","article-title":"Endothelial expression of endocan is strongly associated with tumor progression in pituitary adenoma","volume":"22","author":"Cornelius","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.ghir.2020.101362_bb0245","first-page":"1","article-title":"Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours","author":"Iacovazzo","year":"2019","journal-title":"Endocrine"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663742030071X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109663742030071X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:51:56Z","timestamp":1761087116000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109663742030071X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":49,"alternative-id":["S109663742030071X"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2020.101362","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial dysfunction in patients with acromegaly and It's association with Endocan","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2020.101362","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101362"}}